COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,738 Articles (22,502 medRxiv, 8,236 bioRxiv)

Most recent first Previous |  Page 255: Articles 2541-2550  | Next

Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagy.
Lee, J. S., Dittmar, M., Miller, J., Li, M., Ayyanathan, K., Ferretti, M. B., Hulahan, J., Whig, K., Etwebi, Z., Griesman, T., Schultz, D. C., Cherry, S.
10.1101/2023.11.13.566859 — Posted: 2023-11-16
The Impact of SIV-Induced Immunodeficiency on Clinical Manifestation, Immune Response, and Viral Dynamics in SARS-CoV-2 Coinfection
Melton, A., Rowe, L. A., Penney, T., Krzykwa, C., Goff, K., Scheuermann, S. E., Melton, H. J., Williams, K., Golden, N., Moore Green, K., Smith, B., Russell-Lodrigue, K., Dufour, J. P., Doyle-Meyers, L. A., Schiro, F., Aye, P. P., Lifson, J. D., Beddingfield, B. J., Blair, R. V., Bohm, R. P., Kolls, J. K., Rappaport, J., Hoxie, J. A., Maness, N. J.
10.1101/2023.11.15.567132 — Posted: 2023-11-16
Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket
Huang, C.-Y., Metz, A., Lange, R., Artico, N., Potot, C., Hazemann, J., Mueller, M., Dos Santos, M., Chambovey, A., Ritz, D., Eris, D., Meyer, S., Bourquin, G., Sharpe, M. E., Mac Sweeney, A.
10.1101/2023.11.15.567102 — Posted: 2023-11-15
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome
Chernov, A., Rodionov, M., Kazakov, V., Ivanova, K., Mesheryakov, F., Kudriaeva, A., Gabibov, A., Telegin, G., Belogurov, A.
10.1101/2023.11.14.567145 — Posted: 2023-11-15
COVID-19-related research data availability and quality according to the FAIR principles: A meta-research study
Sofi-Mahmudi, A., Raittio, E., Khazaei, Y., Ashraf, J., Schwendicke, F., Uribe, S. E., Moher, D.
10.1101/2023.11.14.566998 — Posted: 2023-11-15
Virological characteristics of the SARS-CoV-2 Omicron HK.3 variant harboring the "FLip" substitution
Kosugi, Y., Plianchaisuk, A., Putri, O., Uriu, K., Kaku, Y., Hinay, A. A., Chen, L., Kuramochi, J., Sadamasu, K., Yoshimura, K., Asakura, H., Nagashima, M., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2023.11.14.566985 — Posted: 2023-11-15
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling
Otter, C. J., Bracci, N., Parenti, N. A., Ye, C., Li Hui, T., Asthana, A., Pfannenstiel, J. J., Jackson, N., Fehr, A. R., Silverman, R. H., Cohen, N. A., Martinez-Sobrido, L., Weiss, S. R.
10.1101/2023.11.15.566945 — Posted: 2023-11-15
Cost-effective boosting allocations in the post-Omicron era of COVID-19 management
Le, T. P., Conway, E., Akpan, E., Abell, I., Abraham, P., Baker, C. M., Campbell, P. T., Cromer, D., Lydeamore, M. J., McDonough, Y., Mueller, I., Ryan, G., Walker, C., Wang, Y., Carvalho, N., McVernon, J.
10.1101/2023.11.14.23298536 — Posted: 2023-11-15
Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades
Dadonaite, B., Brown, J., McMahon, T. E., Farrell, A. G., Asarnow, D., Stewart, C., Logue, J., Murrell, B., Chu, H. Y., Veesler, D., Bloom, J. D.
10.1101/2023.11.13.566961 — Posted: 2023-11-14
SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells
Abrozek-Latecka, M., Kozlowski, P., Hoser, G., Bandyszewska, M., Hanusek, K., Nowis, D., Golab, J., Grzanka, M., Piekielko-Witkowska, A., Schulz, L., Hornung, F., Deinhardt-Emmer, S., Kozlowska, E., Skirecki, T.
10.1101/2023.11.13.566917 — Posted: 2023-11-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).